Sildenafil Citrate in Waldenstrom's Macroglobulinemia

Clinical trial NCT00165295 · COMPLETED

Trial details

NCT number: NCT00165295
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Waldenstrom's Macroglobulinemia

Start date: 2005-09-01
Primary completion: 2007-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.